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Abstract  24 
Objectives: The goal of this study was to describe the clinical presentation, diagnosis 25 
and treatment of coccidioidomycosis in cats residing in a region endemic for 26 
Coccidioides species.  27 
Methods: A retrospective review of records was performed at both primary and tertiary 28 
care veterinary practices in Tucson and Phoenix, AZ. Data collected included 29 
signalment, clinical signs, physical exam findings, diagnostic test results, treatment and 30 
outcome.  31 
Results: Fifty-one feline cases were identified from six different veterinary hospitals. 32 
Cats presented with clinical signs and laboratory abnormalities similar to what has been 33 
seen in dogs, including respiratory illness (20/51), neutrophilia (24/31), monocytosis 34 
(17/31), and hyperglobulinemia (16/30). However, cats at diagnosis were typically 35 
significantly ill, with 31/51 having disseminated infection, most commonly to the skin 36 
(n=22). Additionally, 43/44 cats that had serum antibody tests performed were positive, 37 
and median titer at diagnosis was 1:32 (range 1:4 – ≥1:256). Serum antibody titers 38 
reduced significantly (P ≤0.001) in cats that responded to treatment compared with cats 39 
that did not clinically improve. 40/46 cats that were treated with oral flucaonzole 40 
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responded and did not require additional therapy. Fourteen cats developed recurrent 41 
disease and all but 1 had antifungal therapy successfully reinstituted.  42 
Conclusions and relevance: Coccidioidomycosis is a disease of concern for cats 43 
residing in the region endemic for Coccidoides spp. Disease is most often disseminated 44 
at the time of diagnosis, possibly due to delays in presentation for care and recognition 45 
of the infection. Suspicion of disease, serum chemistries, blood cell counts, presence of 46 
antibody, and imaging aid in diagnosis of coccidioidomycosis in cats. Serum antibody 47 
reduction during treatment frequently correlated with an adequate response to 48 
medication. Consideration of coccidioidomycosis as a cause of illness will lead to 49 
earlier diagnosis and potentially better treatment outcomes in cats. 50 
  51 
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Introduction  52 
 Coccidioidomycosis, also known as Valley Fever, is a fungal disease prevalent 53 
in semiarid regions of the western hemisphere. In the United States, endemic regions 54 
are found in Arizona, California and parts of New Mexico, Texas, Nevada and Utah.1,2 55 
Recently, several locally acquired human cases were identified in eastern Washington 56 
state.3,4 The causative agents are the dimorphic fungi Coccidioides immitis and C. 57 
posadasii, with no noteworthy variances in the disease course between the two species.5   58 
Infection is acquired by inhalation of the 3 – 5 µm arthroconidia (spores) which 59 
grow from mycelia in the soil and are very easily aerosolized by natural or human-60 
caused disturbance, such as digging, wind or construction.1 In the lungs, the tiny spores 61 
easily reach the distal airways and rapidly transform into the parasitic spherule phase. 62 
Rapid expansion of the fungus by endosporulating spherules results in a respiratory 63 
infection ranging from subclinical to severe. In hosts that are unable to control the 64 
infection early, Coccidioides species may disseminate via the bloodstream to virtually 65 
any extrapulmonary tissue.1,6   66 
Published literature on dogs with coccidioidomycosis cites a wide variety of 67 
clinical presentations, dependent on involved organ systems, but coughing, lethargy and 68 
anorexia are the most common features, followed by lameness from osteomyelitis.6-8 69 
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Typical clinicopathological findings in dogs include hyperglobulinemia, monocytosis 70 
and hypoalbuminemia.9,10 Less information is available about the disease in cats. At one 71 
time, cats were believed to be resistant to infection by Coccidioides species;11 however, 72 
published case reports have proven this to be incorrect.5,11-13 As the historic incidence of 73 
coccidioidomycosis is not known in cats, it cannot be ascertained whether infections are 74 
increasing or whether veterinarians are more aware of the disease in this species.   75 
The purpose of this retrospective study was to learn more about how 76 
coccidioidomycosis presents, progresses, and is treated in the feline species.  77 
Materials and Methods 78 
Study Design and Case Selection: A retrospective record review of feline 79 
coccidioidomycosis cases was performed at six veterinary practices in Arizona - three 80 
feline only practices, two specialty referral hospitals and one general small companion 81 
animal practice (four in Tucson, two in Phoenix). Records between 2004 and 2018 82 
(where available) were searched for potential cases. All database searches were 83 
performed by staff at each clinic, except for one specialty hospital in Tucson. At that 84 
location, investigators performed the database search for the available years (2011 to 85 
2018) using the search terms “coccidioidomycosis,” “cocci,” and “Valley Fever.” Cases 86 
were included in this study if they were definitively diagnosed via cytology, histology 87 
Arbona N, Butkiewicz CB, Shubitz LF, et al 
 
or culture or if they had at least two of the following: clinical signs that can be related to 88 
coccidioidomycosis in other species, positive anticoccidioidal antibody serology, 89 
clinicopathological changes similar to canines and radiographs supportive of the 90 
diagnosis. Cases were excluded if inadequate information was available and if the 91 
diagnosis was inconclusive.   92 
Data Collection: Medical records were reviewed by one of the authors. The data 93 
collected included signalment, lifestyle, clinical signs, complete blood cell count 94 
(CBC), serum chemistries, radiographs or other imaging, coccidioidal serology, 95 
treatment and outcome. As multiple diagnostic laboratories were used, 96 
clinicopathological data was collected as the laboratory interpretation rather than the 97 
raw data. Coccidioidal serology was performed by commercial laboratories, which used 98 
agar gel immunodiffusion (AGID) to identify antibodies (IgG and IgM) and quantitate 99 
IgG. Semi-quantitation of IgG is obtained by serial dilution of positive serum and an 100 
endpoint titer is reported.  101 
Statistical Analysis: Descriptive analysis of collected data was performed in Microsoft 102 
Excel (2016). Data were migrated to GraphPad Prism version 7.00 for Windows 103 
(GraphPad Software) for statistical analysis. The non-parametric Mann-Whitney U test 104 
was performed to compare titers. Significance was set at P ≤0.05. 105 
Arbona N, Butkiewicz CB, Shubitz LF, et al 
 
Results 106 
Case inclusion: Fifty-one feline cases of coccidioidomycosis were included in the 107 
analysis. While demographic data of the hospital populations was largely unavailable, 108 
we were able to obtain estimates of patient visits for 2 hospitals (1 feline only, 1 109 
specialty). For these 2 clinics, the feline coccidioidomycosis cases represented 0.23% 110 
and 0.15%, respectively, of the feline patient visits. 111 
Signalment: Most of the cats were domestic crossbreeds (n = 46, 90%). There was one 112 
of each of the following breeds: Abyssinian, Himalayan, Maine Coon, Persian, and 113 
Siamese. Age at diagnosis ranged from 1 year to 15.5 years (mean = 6.8 years, SD = 4). 114 
There were 30 neutered males (59%) and 21 females (41%), of which all but one was 115 
spayed. Most cats were reported as indoor only (n = 30), with 15 indoor/outdoor and 116 
one outdoor only. Lifestyle information was unavailable for five cats. Body weights at 117 
time of diagnosis ranged from 1.86 kg to 7.82 kg (mean = 4.58 kg, SD = 1.27). 118 
Eighteen cats had lost weight from a previous visit while 12 cats had no weight loss. 119 
Information about previous weight was unavailable for 21/51 of the cats. Five cats had 120 
comorbidities that could have affected immune function. These were feline 121 
immunodeficiency virus (n = 3), feline leukemia virus (n = 1) and diabetes mellitus (n = 122 
1). 123 
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Clinical signs: Clinical signs at presentation are summarized in Table 1. Dermal lesions 124 
were the most commonly reported complaint (n=22, 43%), with most of those lesions 125 
described as nodular (13/22). Additional descriptions of dermal lesions included non-126 
healing wounds (7/22) and crust or plaque-like lesions (2/22). Respiratory signs were 127 
present in 20 (39%) cats. These cats were described as having some form of respiratory 128 
distress (14/20), including tachypnea, wheezing, or labored breathing. Six of the 20 cats 129 
presented with a cough only, while 12/20 cats had both a cough and respiratory distress 130 
described. Signs associated with systemic illness, such as decreased appetite or anorexia 131 
(n=14) or fever (≥103°F or 39.4°C, n=4) were less frequently reported. Lameness, 132 
paresis or paraparesis was seen in 11 (22%) cases.  133 
Radiography and imaging: Radiographs were acquired in 22 cats at the time of 134 
diagnosis (19 thoracic, two thoracic and skeletal and one skeletal only). One cat had a 135 
thoracic ultrasound performed and four cats had both thoracic ultrasound and 136 
radiographs performed. Results are summarized in Table 1. Half of the cats had 137 
multiple radiographic abnormalities noted. Overall, a bronchial, interstitial and/or 138 
alveolar pattern or consolidation of one or more lung lobes were noted most frequently 139 
(n = 9 [41%] each). Hilar lymphadenopathy was observed in six (27%) of the cases. 140 
Four cats (18%) had solitary lung masses/nodules and five (24%) had pleural effusion. 141 
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(Figure 1) All three cats with skeletal radiographs performed were found to have an 142 
osteomyelitis characteristic of fungal infection in a forelimb. Thoracic ultrasound 143 
showed pericardial effusion in two cats. One cat had a computed tomography scan of 144 
the thorax. (Figure X)  145 
Hematology and Serum Chemistries: Thirty cats had serum chemistries and a CBC 146 
performed at the time of diagnosis and one additional cat had only a CBC performed. 147 
Three cats (6%) had no abnormalities noted on either the serum chemistries or the CBC. 148 
Neutrophilia was present in 24 (47%) cats, monocytosis was present in 17 (33%) cats, 149 
and hyperglobulinemia was present in 14 (27%) cats. (Table 3)   150 
Serology: Forty-four cats had coccidioidal serology performed at the time of diagnosis 151 
and 43 were seropositive. Titers ranged from 1:4 to ≥1:256 (median 1:32). The seven 152 
cases in which serology was not performed were definitively diagnosed through 153 
cytology, histopathology or culture, as was the seronegative cat. Post-diagnosis 154 
serology results were available for 40 cats. The latest available serology result for each 155 
of these 40 cats was compared to the serology results at diagnosis, with the available 156 
follow up time ranging from 2 months to 12 years (mean = 2.76 years, SD = 2.67). The 157 
post-diagnosis serology results ranged from negative to ≥1:256 (median ≤1:4).  158 
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The 40 cats with follow up serology were divided into two groups based upon 159 
whether there was clinical improvement after treatment was initiated. Thirty-three cats 160 
were clinically improved compared with the time of diagnosis, with the follow up 161 
examination and serology occurring as early as 3 months post-diagnosis. Seven cats 162 
were clinically worse. Interestingly, all of these cats were about 1 year post-diagnosis at 163 
the time this assessment was made. On average, the cats with clinical improvement had 164 
the titer decrease by three dilutions, while cats that were not clinically better had an 165 
average increase of the titer by one dilution. There was a statistically significant 166 
difference in the change in quantitative dilutions between these groups (P ≤0.001).  167 
Clinical pathology: Cytology, histology and/or culture were performed and confirmed 168 
the diagnosis of coccidioidomycosis in 18 (35%) of the cats in the population; all but 169 
one of these cats had disseminated disease. The most common confirmed site of 170 
dissemination was to the cutaneous or subcutaneous tissue (n = 6), followed by ocular 171 
tissue (n = 4). One cat each had dissemination to the pleural space, a cranial thoracic 172 
mass, the liver and an extradural mass. Four cats had positive culture and/or cytology 173 
from multiple sites.  174 
Disseminated disease: In addition to the 17 cats that received a confirmation of 175 
extrapulmonary dissemination through histology, cytology or culture, 14 cats (27%) had 176 
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a combination of evidence supporting a diagnosis of disseminated disease by the 177 
treating veterinarian, although etiologic testing was not pursued. Of these, nine cats had 178 
dermal lesions consistent with coccidioidomycosis. Two cats had skeletal radiographic 179 
changes characteristic for fungal osteomyelitis. Two cats had both dermal and ocular 180 
disease and one cat was believed to have dissemination to the skin, eye, and tongue 181 
based on records. Sites of dissemination are summarized in Table 4.   182 
Treatment: Treatment was instituted in 50/51 cats, while the remaining cat was 183 
euthanized at diagnosis due to the severity of the disseminated disease. The most 184 
commonly prescribed antifungal was fluconazole as sole agent and the typical dosage of 185 
fluconazole was 50 mg/cat PO q12h. Itraconazole was the only other antifungal drug 186 
given as the first line agent.  187 
Forty-six (92%) cats were treated with fluconazole initially and 40 of those 188 
never received another antifungal drug. Six cats received additional antifungal drugs, 189 
either concurrently or sequentially, due to failure to respond to fluconazole alone. 190 
Additional antifungal drugs included itraconazole, amphotericin B, posaconazole and 191 
terbinafine. Twenty-five cats were still receiving oral antifungal medication at the time 192 
of the review (22 on fluconazole, 2 on itraconazole, and 1 on posaconazole). For this 193 
group of cats, the time on antifungal medication ranged from 6 months to 7.5 years.  194 
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Itraconazole was instituted as the initial treatment in the other four (8%) cats. 195 
One of these cats was maintained on itraconazole only. One cat, which had severe 196 
skeletal disease requiring amputation of the affected limb, was changed to fluconazole 197 
post-amputation. The remaining two cats received multiple therapies. Treatment is 198 
summarized in Table 5.   199 
A recurrence of coccidioidomycosis was described in 14 cats. All of these cats 200 
received additional antifungal therapy, which was successful in 13/14. Fourteen cats 201 
were deceased at the time of the review. As previously described, 1 cat was euthanized 202 
at diagnosis due to the severity of disease and 1 was euthanized after failing to respond 203 
to antifungal therapy after a recurrence of disease. Five cats were euthanized for 204 
unrelated medical conditions, and the circumstances of the death or euthanasia could 205 
not be determined for the remaining 7 cats.  206 
Discussion 207 
 Reports of cats with coccidioidomycosis have appeared in the literature only 208 
within the past five decades and constitute a few case reports and retrospective 209 
reviews.5,11,12,14,15 These cases represent a small fraction of the cats residing within the 210 
endemic region for Coccidioides species. While coccidioidomycosis is reportable in 211 
humans in Arizona, it is not currently reportable in veterinary species, allowing only for 212 
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estimates of the impact of disease in our animal populations. Previous work has shown 213 
that the rates of infection and disease in dogs are similar to or higher than those seen in 214 
people;16 however, the frequency of disease and subclinical infection in cats is 215 
unknown.    216 
 In this study population, the average age at diagnosis was 6.8 years, which is 217 
similar to cats in a previous retrospective study.11 Two-thirds of the cats diagnosed with 218 
coccidioidomycosis lived exclusively indoors at the time of diagnosis, suggesting that 219 
being outdoors exposed to soil is not requisite for acquiring infection. This has also 220 
been noted in cats with blastomycosis,17,18 cryptococcus,19 and histoplasmosis.20 Spores 221 
may be introduced to indoor cats through air conditioners, open doors and windows or 222 
on fomites that enter the residence (people, other animals). 223 
 Though primary pulmonary disease with a cough is the most common 224 
presentation of coccidioidomycosis in dogs and humans,2,8 respiratory disease has been 225 
previously reported to be present in only 25% of cats.11 In contrast to previous findings, 226 
40% of the cats in this population exhibited significant respiratory signs. Interestingly, 227 
hilar lymphadenopathy was not frequently identified on the thoracic radiographs of this 228 
cohort, despite being a common finding in dogs with coccidioidomycosis.10,21,22 What is 229 
most notable about cats is that >60% of this population had disseminated disease at the 230 
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time of diagnosis, and nearly half of all the cats in this study had dermal lesions as the 231 
primary feature leading to diagnosis of coccidioidomycosis. For all cats residing in the 232 
endemic region, even those exclusively indoors, coccidioidomycosis should be 233 
considered as a differential diagnosis for antibiotic-unresponsive dermal lesions, 234 
respiratory distress or cough, pleural effusion, ocular disease, chronic skeletal 235 
pain/lameness or paresis/paralysis. Coccidioidomycosis should be strongly considered 236 
in cats that present with chronic dermal lesions that do not respond to empirical 237 
treatment.  238 
Clinicopathologic abnormalities were more common in this feline population 239 
compared to previous reports.11 The most common abnormalities were 240 
hyperglobulinemia, neutrophilia, and monocytosis, which are supportive of a diagnosis 241 
of coccidioidomycosis based on canine disease.9,10 While the CBC and serum 242 
chemistries can aid in the diagnosis of coccidioidomycosis, the lack of inflammatory 243 
parameters cannot rule out coccidioidomycosis in cats.  244 
Agar gel immunodiffusion uses doubling serial dilutions of serum to quantitate 245 
anticoccidioidal antibody levels. The assay has been demonstrated to have high 246 
specificity for anticoccidioidal antibodies, although there are no published validity 247 
studies of its use in felines.23 In dogs, overlap in titers has been shown with clinical and 248 
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subclinical disease and the magnitude of the titer does not consistently correlate with 249 
the presence or severity of illness.16 Additionally, negative serology does not rule out 250 
coccidioidomycosis in humans or dogs.9,21,24 The overwhelming majority of the cats in 251 
this study that were tested did have anticoccidioidal antibodies, which is similar to the 252 
only other review of feline coccidioidomycosis, in which all affected cats were 253 
seropositive.11 At this time, the rates of healthy seropositive cats as well as seronegative 254 
cats with clinical coccidioidomycosis is unknown. A serosurvey of both healthy and 255 
sick cats, as has been done in dogs,16 would be needed to determine this information. 256 
Interestingly, the single seronegative cat in this case series did have histological 257 
confirmation of infection. 258 
Confirmation of the presence of the fungus through histopathology, cytology, 259 
and/or fungal culture is considered the gold standard for diagnosis; however, dogs are 260 
typically diagnosed through a combination of clinicopathology, diagnostic imaging and 261 
relevant clinical signs.6 The large number of cats in this study with confirmed 262 
coccidioidomycosis is likely due to two factors: 1) the frequency of and 2) the location 263 
of dissemination. Extrapulmonary dissemination is rare in humans.2,25 It appears to be 264 
more common in canines, with previous studies showing dissemination rates from 20% 265 
to 42% of cases.10,26 The most common site of dissemination in canines is to the skeletal 266 
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system and biopsy is infrequently pursued due to cost and invasiveness of the testing as 267 
well as a strong radiographic indication of disease. However, the dermatologic 268 
dissemination seen in cats5,11,12,15 allows for easily obtained aspirates and biopsies. 269 
Also, the specimens for definitive diagnosis are usually obtained after lesions have 270 
failed to respond to antimicrobial or other empiric treatments. Two cats in this study 271 
had confirmed dissemination to the skeletal system, but one cat was confirmed on 272 
necropsy and the other was confirmed upon amputation of the limb. The two cats with 273 
suspected skeletal dissemination based upon radiographs did not have confirmatory 274 
biopsy performed.  275 
Most cats in this study were treated with the oral antifungal fluconazole, as is 276 
typical for dogs in Arizona.6 Fluconazole, while fungistatic, has the advantage of a high 277 
bioavailability and excellent tissue penetration.27,28 The tissue penetration makes 278 
fluconazole a particularly good choice due to the level of disseminated disease in 279 
multiple tissues, including ocular, seen in these cats. It is likely that fluconazole was 280 
chosen due to convenience, availability and familiarity, but it appears that most cats 281 
were treated successfully with it. Most of the cats in this study that were successfully 282 
treated required medication for over a year, and often several years. Recurrence of 283 
disease was evident in over a quarter of the cats in this cohort, although all but one of 284 
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the cats were treated to clinical remission. While coccidioidomycosis in cats may 285 
require lengthy treatment with antifungal therapy and monitoring for recurrence, overall 286 
most cats will respond to treatment.  287 
 A limitation of this study is the retrospective nature of data collection. In order 288 
to identify the greatest number of cases, we purposefully approached feline only and 289 
specialty hospitals. This may have created a bias towards cats that were more ill at the 290 
time of diagnosis. However, the cases from the general small animal practice in Tucson 291 
did not have notable differences in the severity of illness. We were reliant upon most of 292 
the veterinary clinics to perform their own database searches and we suspect that the 293 
true number of feline coccidioidomycosis cases is underrepresented in this review. We 294 
were also unable to control for radiographic interpretation, diagnostic laboratory, and 295 
recommendations made to owners. There is currently no information regarding the 296 
number, sex, lifestyle, and breed of cats living in Tucson and Phoenix, making it 297 
impossible for us to identify risk factors for disease. A longitudinal study of 298 
coccidioidomycosis in cats would provide stronger evidence about the presentation of 299 
disease and outcome for cats residing in the endemic region.  300 
 The cases in this study indicate that cats experience significant clinical disease 301 
as a result of infection with Coccidioides species. Extrapulmonary dissemination was 302 
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evident in over half of the cats, often with spread to multiple organ systems. It is 303 
possible that the independent nature of cats and their ability to hide subtle indications of 304 
illness leads them to be diagnosed later in the course of disease. However, most of the 305 
cats in this study were reported to live exclusively indoors, suggesting that this 306 
population of cats did have owners who could monitor their cats daily for behavioral 307 
changes indicating illness. The extent of disease associated with coccidioidomycosis 308 
reported here and in previous work11 may indicate a difference in host control of disease 309 
compared with dogs or humans.     310 
Conclusions  311 
 Coccidioidomycosis presents a diagnostic challenge in any species due to the 312 
overlap of clinical signs, clinicopathologic changes and radiographic abnormalities 313 
between coccidioidomycosis and other diseases. The results of our study indicate that 314 
clinical suspicion of coccidioidomycosis should be high in cats with dermatologic 315 
lesions or severe respiratory illness. Positive serology appears to be well correlated with 316 
clinical illness, although biopsy and culture samples can provide a definitive diagnosis. 317 
Orally administered fluconazole was the treatment of choice in this population of cats 318 
and proved to be effective in most animals treated.  319 
 320 
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Figure   410 
Figure 3. Coronal section of thorax (A) and sagittal section of thoracic spine (B) of a SF 411 
domestic shorthair with acute onset of hind limb paralysis.  (A) The thoracic section 412 
shows an enlarged mediastinal lymph node (LN) as well as a fungal granuloma (G) and 413 
pulmonary infiltration in the right cranial lung lobe. (B) There is a contrast-enhancing 414 
space occupying lesion of the spinal cord.  Coccidioides was identified ….. by  ….. and 415 
the cat responded completely to oral fluconazole.  416 
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Table 1: Presenting clinical signs 417 
 n (%) 
Respiratory signs 20 (39%) 
Respiratory distress 8 (40%) 
Cough 7 (35%)* 
Both 5 (25%)* 
Fever 4 (9%) 
Anorexia/decreased appetite 14 (27%) 
Weight loss 18 (35%) 
Lameness/paraparesis/paresis 11 (22%) 
Dermatologic lesions 22 (43%)** 
Nodules 13 (59%)* 
Non-healing wounds 8 (36%)* 
* These reflect the percentage of animals that presented with that category of clinical signs; ** One cat 418 
with dematologic lesions did not have a description of the lesions provided in the record 419 
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Table 2: Radiographic abnormalities noted 421 
 Radiographic Changes n 
Single 
Radiographic 
Abnormality 
Noted 
Hilar Lymphadenopathy  1 
Bronchial/Interstitial/Alveolar Pattern 4 
Lobe Consolidation 1 
Mass/Nodule  2 
Pleural Effusion 2 
Osteomyelitis 1 
Multiple 
Radiographic 
Abnormalities 
Noted 
Hilar Lymphadenopathy & Lobe Consolidation 2 
Hilar Lymphadenopathy &  Bronchial/Alveolar/Interstitial Pattern 2 
Hilar Lymphadenopathy, Lobe Consolidation, &        
Bronchial/Alveolar/Interstitial Pattern 
1 
Bronchial/Interstitial/Alveolar Pattern & Lobe Consolidation 1 
Bronchial/Interstitial/Alveolar Pattern & Pleural Effusion 1 
Pleural Effusion & Lobe Consolidation 2 
Lobe Consolidation,  Mass/Nodule, & Osteomyelitis 1 
Bronchial/Interstitial/Alveolar Pattern & Osteomyelitis 1 
* 22 cats had radiographs (19 thoracic only, 1 skeletal only, and 2 thoracic and skeletal) 422 
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Table 3: Serum chemistry and CBC abnormalities 423 
 n (%) 
Neutrophilia 16 (53%) 
Monocytosis 12 (40%) 
Hyperglobulinemia 13 (43%) 
Hypoalbuminemia 7  (23%) 
Table 4: Sites of Dissemination 424 
Location Confirmed (n=17)* Suspected (n=14)† 
Cutaneous/subcutaneous 7 12 
Ocular 5 3 
Pleural Effusion 1 0 
Hepatic 2 0 
Skeletal 2 2 
Tongue 2 1 
Extradural mass 1 0 
Pericardium 1 0 
Joint 1 0 
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Spleen 1 0 
Lymph Node 1 0 
*4 cats within this group had confirmed dissemination to multiple sites; †3 cats within 425 
this group had suspected dissemination to multiple sites 426 
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Table 5: Antifungal Treatments 428 
Initial 
Treatment Additional Therapies 
Fluconazole 
(n=46) 
none (n=40)* 
itraconazole (n=4) 
itraconazole, terbinafine, amphotericin B, posaconazole (n=1) 
posaconazole, itraconazole (n=1) 
Itraconazole 
(n=4) 
none (n=1) 
fluconazole (n=1) 
fluconazole, amphotericin B, terbinafine (n=1) 
fluconazole, amphotericin B (n=1)† 
*One cat in this group had amphotericin B discontinued after one dose due to rising 429 
renal values; the cat was then maintained on fluconazole alone 430 
†This cat was euthanized approximately one year after diagnosis due to worsening 431 
disseminated disease 432 
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